WELCOME VISITORS
البــدايَـــة

Web Counter

تنبيـه هَـام

** المعلومات الموجودة بالموقع مُسجلة كملكية فكرية خاصة لأصحابها، ويُمنع نشرها إلا بإذن قانوني من إدارة الموقع، وذلك تنبيهًا حتى لا تنال المُخالفين يد القانون.

إدارة الموقع

شـبكة مَواقعنـا
طاقات مُتجدِّدَة لِخدمة الإنسَانيَّة

موقعنا المتخصص في:

العِلاج بالطاقة الحَيَويَّة

وتقديم الاستشارات المجــانيَّة

www.aah3.com

 

موقع المركز الدولي للطاقة الحيوية

المختص بالتدريب على طرق العلاج بالطاقة الحَيَويَّة المُختلفة

www.icve.net

 

موقع المركز الدولي  المُختص بتسويق الأجهزة والمعدات والمستلزمات الطبيَّـة

والأعشاب والزيوت الطبيَّة

وباقي منتجاتنا الأخرى...

www.icve.org

 

موقع المجمُوعة الدولية  الرابطة العالمية لرعاية المُعالجين بالطاقة الحَيَويَّة وتقديم الدعم لهم...

www.igve.net

 

الموقع الشامل الذي يضم: مواقع أعضـاء المجمُوعة الدوليَّة المُعالجين بالطاقة الحَيَويَّة

www.igve.org

 

موقع نور الفجر الجديد

أمل يشرق في الآفاق

على ربُوع الأمة بالخير

www.idve.net

 

الموقع الدولي للحجامة

المختص بتقديم الأدوات للمعالجين بالحجامة.. والتدريب للمُمارسين...

www.ahp1.net

 

مجموعة ملتقى

رجال الأعمال

تقدم أقوى عروض استضافة للمواقع

بأقل الأسعـار

 www.egvip.com/new

 

موقع نت مصر

يقدم خدمات الإنترنت

بحرفية عالية جدا

وبأسعار منافسة عالميًا

www.netmasr.com.egvip.com

 
 
***   مجموعة مواقعنا الأضخم على الشبكة الدولية المتخصصة في تقديم خدمات التدريب العملي.. والاستشارات المجانية.. وخدمات العلاج بالطاقة الحيوية.. وتقديم الدعم للمعالجين بالطاقة الحيوية حول العالم          مجموعة مواقعنا الأولى في الوطن العربي المتخصصة في التدريب على أنواع العلاج بالطاقة الحيوية المختلفة          مجموعة مواقعنا الأولى في الوطن العربي التي تقدم استشارات مجانية في جميع أنواع العلاج بالطاقة من أفضل خبراء العلاج بالطاقة الحيوية          انضموا إلى باقة المجموعة الدولية للطاقة الحيوية لتكونوا في موقع الصدارة          مجموعة مواقعنا الأضخم على النت باللغة العربية التي تقدم فنون وأدوات وخامات العلاج بالطاقة الحيوية تحت إشراف نخبة من الخبراء والمختصين في العلاج بالطاقة الحيوية          نحن نسعى دائما إلى نشر خبرات العلاج بالطاقة الحيوية بعمل دورات تدريبية.. كما نسعى لنشر التفاصيل الصحيحة لأنواع العلاج بالطاقة الحيوية          مجموعة مواقعنا حاصلة على عدد كبير من الشهادات عن نشاطها في مجال التدريب في الشرق الأوسط          دوراتنا مستمرة حول أنواع العلاج بالطاقة الحيويَّة          انضموا إلى دوراتنا التدريبية بالمراسلة المتاحة للجميع.. وانضموا إلى عضويتنا لكي تحصلوا على المزايا العديدة لخدماتنا          اطلبوا مطبوعاتنا المختلفة التي تتناول طرق العلاج بالطاقة الحيويَّة          لدينا كافة أدوات عمل الحجامة بأسعار الجملة          لدينا أجهزة وإبر العلاج بالإبر الصينية العادية والماجنتيك بمقاساتها وأنواعها          لدينا أنواعا متميزة من الأجهزة الطبية والأجهزة التعويضية والمساعدة بأقل الأسعار          لدينا جهاز شانيل لتنشيط قنوات الطاقة الحيوية بالجسم          لدينا جهاز ميكروكمبيوتر للتشخيص والعلاج          لدينا أجهزة ألتراسونيك المتعددة لتنبيه العضلات.. والتخسيس          لدينا جهاز تخليص الجسم من السمُوم عن طريق القدمين          لدينا أجهزة من الاتحاد الأوربي ومن الصين للاستخدامات العلاجية.. بأسعار الجملة          لدينا الأدوات التي تساعد المعالجين بالطاقة الحيوية على أداء واجباتهم بتميز وكفاءة عالية          لدينا المزرعة الوحيدة في الشرق الأوسط لإنتاج الإسبرولينا الأفضل في العالم بخواصه ومواصفاته القياسية          لدينا إنتاج الشيتوزان بأعلى معايير الجودة العالمية          لدينا إنتاج طبيعي مائة بالمائة للأعشاب والنباتات الطبية بدون إضافات أو مواد كيميائية أو هرمونات          لدينا أفضل إنتاج للزيوت الطبية على البارد          يمكنكم المُتاجرة والربح معنا.. انضموا إلى وكلائنا المتميزين في كل مكان          معنا تصبح وكيلا ناجحا في بلدك أينما كنت          معنا تبني شراكة متميزة تحقق بها أحلامك          لدينا منتجع الأهرام للطاقة الحيوية وهو المنتجع الوحيد في مصر الذي يهتم ويعتني بالنواحي الصحية والنفسية والبدنية في وقت واحد.. ويسرنا استقبالكم في المنتجع بأجمل الأماكن الصحية الساحرة في قلب الطبيعة بمنطقة الأهرام على مشارف القاهرة.. لكي نقدم لكم أفضل ما لدينا من خبرات علاجية متميزة جدا بأقل التكاليف          لدينا دائما كل ما هو جَديد في طرق وأجهزة وأدوات وخامات وخبرات العلاج بالطاقة الحيويَّة بفضل من الله تعالى وتوفيقه ***

  ENGLISH SITE

اتصـل بنـا
 
 

 

موقع: الدكتورة/ نصـرة حمُّـود

DR: NASRA HAMMOUD

جولة في سيدي بوسعيد في تونس العاصمة

دراسة: مقارنة تأثير بين فاکهة التمر والحقنة الأوکسيتوسين

علی کمية النزيف بعد الولادة الطبيعية باللغة الإنجليزية

 

Comparing the efficacy of dates and oxytocin

in the management of postpartum hemorrhage

 

short running head: Dates, Oxytocin and postpartum hemorrhage

Hammod N1. Latifnejad R2.Khadem N3.

1. Hammod Nasreh

 Address: Jorjani university, Doctora Crossroads,  Mashhad, Iran.

2. Latifnejad Robab

 Address: Jorjani university, Doctora Crossroads,  Mashhad, Iran.

3. Khadem Nayereh

Imam Reza hospital, Associated professor of Gynecology and Obstetrics. Mashhad university of medical science, Iran. Address: Mashhad university of medical sciences, university street, Mashhad, Iran.

 

Abstract:

Background: The purpose of this study was to compare the effects of dates and intramuscular oxytocin for the prevention of postpartum hemorrhage.

Objective: Use of dates after delivery effect in postpartum hemorrhage.

Design: We have compared 50 gram of Deglet Noor dates (group A) with 10 units intramuscular oxytocin (group B) in for managing postpartum hemorrhage in 62 women in a prospective and randomized clinical trial.

Immediately after placental delivery, 50 gram oral Deglet Noor dates and 10 unit  of intramuscular oxytocin were given to the groups. At the same time a Plastic and cotton sheet were widen beneath the buttocks and fresh perineal pad was placed on the perineum to absorb blood or fluid. All pads and gauzes were collected until 3 hour after placental delivery and were weighed every one hour. The difference in after and before weight was calculated.( 100 gram increase in weight was considered to be equivalent to 100 ml blood).

Result: Blood loss mean in the end of first hour after delivery were significantly different in date and  oxytocin groups (104 ml vs 141.6 ml, p=0.043), But in second and third hour were not significant, although the blood loss in date group was less. In whole three hours after delivery the blood loss mean in dates group was significantly less oxytocin group (162.5 ml vs 220.7, p=0.02).

Conclusions: Use of oral dates after delivery decreases blood loss more than intramascular oxytocin and it´s a good alternative in normal delivery.

Key Words:postpartum hemorrhage, oxytocin, date/dates.

 

Text

INTRODUCTION

Every year, about 210 million women become pregnant. Postpartum hemorrhage (PPH) is one of the major complications of pregnancy, accounting for 14 million cases annually. Of these, it is estimated that around 140,000 women die, resulting in a case fatality rate of 1%1 Adequate attendance to this complication can mean the difference between life and death2.Therefore Postpartum hemorrhage is a significant cause of maternal morbidity and mortality[3-5].

The World Health Organization defines postpartum hemorrhage as blood loss of 500 mL or more in the first 24 hours postpartum[1,5,6]. Most postpartum hemorrhages are caused by uterine atony and occur in the immediate postpartum period5,6and without warning even in women without any of the known risks for this condition1. Active use of oxytocin to reduce blood loss after delivery  initially started in 1930 and today it is used allover the world for this purpose. It is claimed that oxytocin  not only shorten the third stage of delivery but also prevent uterine atony and blood loss after delivery 7,8. It has been reported that its prophylactic recommendation reduces the blood loss after delivery from 10% to 6%. In other words, it can reduce it by 40% 9. Studies found oxytocin to be preferable to misoprostol in settings where active management is the norm. However, secondary clinical effects may prove more troublesome with oxytocin than with misoprostol, and misoprostol may prove to be more practical and equally effective in low-resource settings4. Of course, in a study controlled taking of oxytocin rather than care was no different10, but in the most controlled studies its effect on reducing blood loss after delivery was widely accepted[9,11,12]. Inappropriate use of oxytocin can sometimes produce potential critical dangers. For instance, an intravenous bolus of 10 units of oxytocin marked fall in arterial blood pressure which can be dangerous specially for patients with hypovolemia problems from hemorrhage or who had cardiac diseases 6 . For treatment of postpartum hemorrhage, two new interventions are also proposed, the anti-shock garment and the balloon tamponade3. Embolization should be offered only after exploration of the uterine cavity, inspection of the vagina, cervix and perineum and failure of uterotonic drugs.13 In modern obstetrics, general trend to utilize non-aggressive treatment methods that is quite safe, cheap and few symptoms. According to the announcement of Ministry of Health and Medicine Education on giving priority to Islamic researches and Holy Koran advice of delivery manner of Mary (Peace be upon her) in verses 22-26 of Mary Surah and interpreterُ perception of these Verses, one of the best foods for women after delivery is date14. For prevent and treatment is better that we use from natural matters such as fruits because they are available, cheap, without adverse and acceptable for pepole. So we take a decision that use of date for management of postpartum hemorrhage because:

 

1- Date fruit has Ca, serotonin, tannin, linoleic acid and Prochcidas anzim that they are important for bleeding control.

2-Date fruit has much glucose that it is the most important source of production of energy in body and also the best food for muscles of uterus.

3- Date fruit causes hypotension in pregnant women for a little time that it causes women have lesser bleeding in delivery and date is laxative which it is cause to facilitate delivery14.

4-There has been no practicable research in this regard. So we have conducted this research with the purpose of studying dateُ effect on hemorrhage rate after delivery and comparing it with oxytocin which has been generally accepted allover the world.

 

METHODS

We have compared 50 gram of Deglet Noor dates[1] orally (group A) with 10 units intramuscular oxytocin (group B) in for managing postpartum hemorrhage in 62 women in a prospective and randomized clinical trial. This study was done in two Mashhad university hospitals, Imam Reza and Hazrat Zeinab for 6 months. The criteria for the subjects to be enter in the study were: age between 20-35, parity being less than 5, gestational age of 38-42 weeks with a living fetus with cephalic presentation, neonatal ُweight between 2500-4000 gram, not being affected by systemic disease, not having any history of cesarian, myoma and any operation on uterus, hemorrhage after previous deliveries, non-existance of polyhydramnios, bleeding, preeclampsia, clearing of  amniotic fluid, non- existence of large episiotomy and finally normality of duration of the third stage of delivery (non- existence intense bleeding after delivery and if there is such state, the subject is going to be excluded from the research). the study According to  sampling method, samples were initially selected based on study purpose and then were randomly classified in two groups. Even numbers were allocated to 31 people as the subject group and odd numbers to 31 people as the witness group. At the being of the forth stage of  labor, immediately after placenta delivery, 50 gram of Deglet Noor dates orally was given to the subject group and 10 units oxytocin injection to the witness group. A pad and a plastic cover was applied to measure the bleeding of one of them. It was measured be weighing the sheets and pads through Pascal Scales, type 100 gram and 1000 gram once in every hour to three hours after delivery. Each gram of overweight in comparison with before delivery was considered equal to 1 ml blood. Blood pressure and pulse were also measuring 15, 30,45,60,120 and 180 minutes after delivery.

In this research, the means of gathering data was interview and observation forms. Interview forms including personal information and data related to present and previous delivery were filled in. Then observation forms containing the data related to the first, second, third and forth stages of labor were completed. Non- parametric data were analyzed using the chi- square and parametric data were analyzed with the Studentُ s t test and mutual variances analysis, using SPSS ( version 11).

Results

 

[1] 1A semi-dry date, possessing a delicate, flavor and firm-textured. Ranging in color from light red to amber to straw. Deglet Noor dates are long, slender and hold their shape very well.

The results indicated that most factors in the date group and oxytocin group were the same, including age, BMI, education, social class and occupation.

The following factors were also the same in the two groups: pregnancy and delivery factors such as abortion, interval between previous and present delivery, the rupture of membrane, induction of labor with oxytocin, duration and dose of oxytocin, interval between stopping oxytocin infusion to delivery, fetal sex, weight and apgar of the first and fifth minute, beginning of sucking nipples and the length of sucking. Table1 showes some personal and delivery futures in  the two groups.

According to the results of mutual variance analysis test, average bleeding in terms of the above-mentioned factors made no significant difference, except for Shoultz placental delivery mechanism in which there was more bleeding after delivery in the date and oxytocin groups (P=0.019) (Fig1).

Active phase of the first stage, the second-stage and the third-stage in the two groups were the same.

The average rate of bleeding in the first hour after delivery in the two groups studied had a significant difference so that bleeding rate in the first hour in the date group was less than the oxytocin group (104 ml V.S 141.6 ml, P=0.043). In the second and third hour after delivery, the bleeding rate made no significant difference ( the second hour P=0.086, the third hour P=0.329), of curse this rate in the date group was lower in the second and third hour. Then,

average of total bleeding during 3 hours after delivery in the two groups was significant difference (P=0.02) and it was lower in the date group that the oxytocin group(162.5ml V.S 220.7 ml). Fig 2 and 3 indicates the bleeding rate in the first, second, third hour and also in total 3 hours after delivery.

 

DISCUSSION

The present research indicates that taking date after delivery in comparison with oxytocin can reduce bleeding rate to a high extend and as it is shown in Fig 2, the average rate of bleeding in the first hour and also average of total bleeding during the first 3 hours after delivery is lower in the date group rather than in the oxytocin group. At the same time, oxytocin injection in the third stage of labor to decrease bleeding has generally been accepted[10,12,15].

And according to similar studies, it has had the same effects as Misoprostol has 16,17and in some other studies, it has been preferred to Ergonovin18.

Akosua et al (1996) reported that using prophylactic oxytocin often prevents atony uterine and bleeding after delivery9.

Nordstorm et al (1997) announced that use of oxytocin in the third-stage of labor more decrease bleeding rather than placebo 8.

The use of intramuscular ergometrine-oxytocin has been studied in a systematic review including six trials totaling more than 9,000 women.11 The combination uterotonic agent was found to be more effective than oxytocin alone for preventing postpartum hemorrhage (NNT = 61). No difference was seen for the prevention of severe postpartum hemorrhage, and there was significantly more nausea and vomiting (NNH = 61) and hypertension (NNH = 96) in the women receiving ergometrine-oxytocin5.

In a systematic review including 17 studies, there was an increased need for therapeutic uterotonic medications (NNH = 22) among the women receiving prophylactic misoprostol when compared with women receiving other injectable uterotonic agents. Side effects from misoprostol were common and included shivering (NNH = 7), vomiting (NNH = 225), diarrhea (NNH = 258), and elevated body temperature (NNH = 18). Although prostaglandins are an effective treatment of postpartum hemorrhage because of the balance of risks and benefits, they currently have no role in the prevention of postpartum hemorrhage.5

No similar study in relation to date effects on bleeding after delivery has been carried out. Dates consumption has been emphasized during pregnancy and after delivery in many Islamic traditions. Dates strengthen uterine muscles and facilitating delivery as well as reduce postpartum hemorrhage 20.

In connection with possible mechanism of date effect on bleeding, one can say that one important factor in preventing from bleeding is Serotonin that there is in date. Studies indicate that this substance is a stimulus of vessel and smooth muscle contraction 21. Tannin and its compounds are also significant factors which involve 1% of the weight of fresh Deglet Noor dates22,23. Tannin can be effect in controlling bleeding24. Among other factors existing in date, we can consider Linoleic acid, Oleic and Starteic 25,26. Linoleic acid can be changed into Arachidonate and then into Ichosanoids. Ichosanoids are 20-Carbon lipoacids that fall into three categories: Prostaglandins, thromboxans and locoterins21. Prostaglandins play an important role in contraction of uterine muscles and bleeding control. Thromboxans cause platelet accumulation and vessel contraction. Leucoterins are substances which affect vessel contraction. Peroxidase enzymes existing in date is a significant factor in bleeding control21.

Date has some basic and significant minerals like iron and ca. In countries with limited resources, where a majority of women have anemia at the onset of their pregnancies, the slightest deviation from normality during labor and/or delivery leading to excessive hemorrhage can put a women's life at risk1.

Ca is an element quite necessary for muscular contraction 21,24. There is usually 50 international units of Vit A, 0.09 mg Vit B1, 0.1 mg Vit B2 and 0.22 mg Thiamin in each 100 gr of date23. In conclusion, date fruit have various nutritious and therapeutic properties mentioned above, can reduce postpartum hemorrhage and can be regarded as a proper substitute for oxytocin.

Acknowledgments

Hammod Nosre writed of the manuscript and consulte

Sharaphy Seyede Afsar designed of the experiment and consulte.

 Latifnejad Robab. designed of the experiment, collection of data and analysis of data.

Khadem Naiere. designed of the experiment, collection of data and analysis of data.

Ibrahimzadeh S writed of the manuscript.

We thank from doctor Hadad and doctor Reza Mazloom for their cooperation.

Refrences:

1.        Nama V, Karoshi M, Kakumani V, The single unit transfusion in post partum hemorrhage: A new perspective. Int J Fertil Womens Med, 2006;51(2):58-63.

2.        Reynders FC, Senten L, Tjalma W, Jacquemyn Y, Postpartum hemorrhage: Practical approach to a life-threatening complication. Clin Exp Obstet Gynecol; 2006: 33(2):81-4.

3.        Appiah A.K. Treatment of sever primary postpartum hemorrhage with a deproteinized hemodialysate, INT J. Gynecol Obstet 2002; 76: 75-76.

4.        Lalonde A, Daviss BA, Acosta A, Herschderfer K, Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet; 2006.

5.        KAREN L. MAUGHAN, STEVEN W. HEIM, M.S.P.H., and SIM S. GALAZKA, Preventing postpartum hemorrhage: managing the third stage of labor. Am Fam Physician; 2006:73(6): 1025-80.

6.        Cunningham FG, Leveno KJ, Bloom SL, et al. Williams obstetrics. 22nd ed,New York, MC Graw-hill 2005.

7.        Jalali Elham,"Evaluation of the effect of oxytocin injection in umblical vein on duration of the third-stage". Thesis MS of midwifery, Mashhad university medical science, Iran, 1994.

8.        Nordstrom-L. "Rotine oxytocin in the third stage of labor: A placebo controlled randomized trial". Br J Obstet Gynecol 1997; 104(7): 781-6.

9.        Akosua NJA De Groot. et al. " A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage ". Acta obstet Gynecol scand, 1996, Vol(75), P: 464 – 68.

10.   Prendiville W, Elbourne DR, Chalmers I. The effects of routine oxytocic administration in the management of third stage of labour, an overview of the evidence from controlled trials. Br J obstet Gynecol 1988; 95 : 3-16.

11.   Prendiville W, Elbourne DR, Stewart GM. The Bristol third stage trial: "acute" versus "physiological" management of the third stage of labour. Br Med. J 1988; 297: 1295 – 1300.

12.   El Refacy H, O Brain P, Morafa W, et al. use of oral misoprostol in the prevention of postpartum hemorrhage. Br J Obstet Gynecol 1997; 104: 336-9.

13.   Pelage JP, Laissy JP, Management of life-threatening postpartum hemorrhage: indications and technique of arterial embolization. J Radiol; 2006, May 87(5): 533-40.

14.   Dayab A, Ghareghose A, medicine in Koran. Tehran,2001.

15.   MC Donald S, prendiville WJ, Elbourne D. prophylactic syntometrine vs oxytocin in the third stage of labor (Cochrane Review). The Cochrane library, Issue 3. Oxford : update software, 1998.

16.   Bugalho A, Daniel A, Faundes A, Cunha M. Misoprostol for

16. prevention of postpartum hemorrhage. Int J Gynecol Obstet 2001; 73:1-6.

17.   Kundodyiwa TW, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. International Journal Obstet & Gyn 2001; 75: 235-41.

18.       Soriano D. et al. "A prospective cohort study of oxytocin alone for prevention of postpartum hemorrhage". British Journal of obstetrics and Gynecology. November 1996, Vol (103), P: 1068-73.

18.

19.   Shirazi Naser, Interpretation of sample, Tehran, Iran.2001

20.   Diab Abdolhamid, Medicine in Holy Koran. 7thed, Manshurat zahedi, Ghom, Iran.1987.

21.   David W Martin, Peter A Mayes, Victor W Radwell, Daryl K Granner. Biochemistry of Harper. 1994.

22.   Hadarmi, G. Personal communication. Chair, Department of animal production, faculty of agriculture sciences, United Arab Emirates University, UAE. 1999.

23.   Rohani Iraj, Date’s book, Tehran University, Iran,1993.

24.   Attalla AM, Harraz FM. Chemical composition of the pits of selected date palm cultivars grown in the Qassim region. Saudi Arabia, Arab Gulf Journal of Scientific Research 1996; 14(3):629-639.

25.   Paulett D R, “ Mosby’s Review series maternity Nursing”. New York, mosby year Book 1996: 370-73.

26.   Vendercook C E.” Quality and nutritive value of dates as influenced by their chemical composition”. Fruit and vegetable chemistry laboratory, U.S. Department of Agriculture, SEA, AR, Pasadena, California 91106.

 
PV

Oxytocin (n=31)

Date (n=31)

Variable

NS**

25± 4.8

24.4±3.9ó

Age (year)

NS

25.1± 2.8

26.2± 4.8

Body Mass Index(BMI)

NS

3.1± 1.6

3.4± 2.2

Pregrancy frequency

NS

38.4±1.4

38.8± 2.7

Gestational age (week)

NS

2.9± 1.8

2.8± 2.6

Delivery frequency

NS

3100±568

3075±559

Weight of fetus(gr)

NS

536±82.1

536±18.03

Weight of placenta(gr)

NS

20.1± 1.3

20.1±2.0

Surface of placenta (cm)

NS

26(83.8

27(87)

Mechanism of Shoults number(percent)

NS

14(45.2)

17(54.8)

Episiotomy number(percent)

NS

8(25.8)

4(12.9)

Tear of degree1,2 number(percent)

óX±SD

óóNS=Not significant , pv< 0.05 significant

 

 

Fig 1: Comparison of average bleeding in terms of placental delivery mechanism in the two group.

 

PV

Date (n=31)

Oxytocin (n=31)

Length of                                 Group

Labor stage

X± SD

X± SD

NS

228.7± 13.3

180.3± 98.8

Active phase of the first stage

NS

31±30.6

23.2±21.5

Second-stage

NS

8.9±4

8.9±3.2

Third-stage

NS= Not significant , pv< 0.05 significant

 

Fig 2: Comparison bleeding average  3 hours after delivery in the two groups.

 

 

 

Fig 3: Frequency distribution of research  units in terms of bleeding in 3 hours after delivery in the two studied group.

Dates

 

 

Deglet Noor dates

 
أمسية مع صديقتها التونسية الأستاذة / مُنية الحمامي  

للعودة إلى الصفحة الرئيسية

للعودة إلى دليل العضـوية

للعودة إلى الصفحة الرئيسية للعُضو

للعودة إلى الأعلى

 
أهـم عـوامل النجَـاح
 

 

** أن تكون موجودا في المكان المناسب.. لاتخاذ القرار المناسب.. في الوقت المناسب.

** انضموا إلى: عضوية المجمُوعة الدولية لتشاركونا النجـاح...

 
المَجموعـة الدوليَّـة للطاقـة الحَيَـويَّـة
 

أقوى

رابطة

عالمية

للمعالجين

 

** تقدم الدعم الإيجابي اللازم لأعضائها أينما كانوا.

** تقدم لكل عضو موقعا دعائيا مُصغرا وترعاه فنيا.

** تمد أعضائها بكل ما يحتاجونه للنجاح في أعمالهم.

** تتواصل وتفتح أمام الأعضاء مجالات للتطوير والتقدم.

** تدعم وتساند أعضائها في طموحاتهم المستقبلية لبلوغ أهدافهم المنشودة.

 
*** جميع المعلومات الموجودة على هذا الموقع من معلومات طبية أو نصائح صحية أو خدمات مجانية تعتبر ثقافية تعليمية بالدرجة الأولى، ولا تستخدم بغرض تشخيص أو علاج أية حالة مرضية دون إشراف الطبيب المعالج، وليست لدينا النية مستقبلاً لإحلالها كبديل للكشف الطبي... إدارة الموقع ***

 Site Designed by The Author office.

Beginning of  The Site:

at 5 March 2005

Site Maintained by Ms: Hoda Abd altawab Hussain, The Author office Manager.

Copyright © 2005, All rights reserved.